|
|
|
|
Science Sparks @ ACTREC
|
 16 June 2025 |
Vol. No. 14 ; Issue No.687 |
|
|
Publications
|
|
1. Arora A, Godse S, Pal M, Misra A, Sepuri RT, Mallikarjun NT, Gujela A, Patel S, Sharma A, Menon S, Bakshi G, Prakash G (2025). Real-world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non-muscle invasive bladder cancer-Implications for global shortage. BJUI Compass.6(6):e70034.
2. Trikha M, Noronha V, Shah M, Patil V, Menon N, Singh A, Chandrani P, Shetty O, Kaushal RK, Pai T, Janu A, Purandare N, Prabhash K (2025). Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in India. Ecancermedicalscience. 19:1867.
3. Gogoi MP, Das P, Das N, Das S, Narula G, Trehan A, Bakhshi S, Radhakrishnan V, Seth R, Tembhare P, Singh Sachdeva MU, Chopra A, Sundersingh S, Parihar M, Bhattacharya R, Banavali S, Saha V, Krishnan S (2025). Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India. Lancet Regional Health - Southeast Asia 37:100593.
4. Punatar S, Kumbhalwar K, Kalantri SA, Gokarn A, Nayak L, Chichra A, Mirgh S, Jindal N, Mathew L, Kannan S, Khattry N (2025). Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemias. Blood Cell Therapy. 8(2):210-216.
5. Ambulkar R, Kunte A, Solanki SL, Thakkar V, Deshmukh B, Rana PS. Impact of prehabilitation in major gastrointestinal oncological surgery: A systematic review. Journal of Gastrointestinal Cancer 56(1):133.
6. Chilukuri S, Sayan M, Pra A, Murthy V (2025). Elective regional nodal Irradiation in prostate cancer. Seminars in Radiation Oncology. 35(3): 374-384.
7. Singh M, Murthy V, Ost P (2025). Debate 3: Metastasis directed therapy in oligometastatic prostate cancer. Seminars in Radiation Oncology 35(3): 423-432.
8. Munne K, Patil P, Mayekar A, Birje S, Bhekare G, Prabhu Valawalkar S, Akula A, Tryambake V, Kamat S, Dalvi R, Tandon D, Surve S, Begum S, Shikhare M, Pimple S, Patil A (2025). Determinants of cervical cancer screening acceptance among women in urban and tribal communities of Maharashtra, India: a cross-sectional study. Cancer Prevention Research
9. Shukla A, Kashyap S, Patil S, Varma AK, Ghosh SK, Kondabagil K (2025). The putative packaging ATPase of acanthamoeba polyphaga mimivirus is an essential protein that interacts with the genome segregation and packaging machinery. FASEB Journal. 9(12):e70685.
|
|
|
|
|
Interesting Reads
|
|
Avet-Loiseau H, Davies FE, Samur MK, Corre J, D'Agostino M, Kaiser MF, Raab MS, Weinhold N, Gutierrez NC, Paiva SB, Neri P, Weisel K, Maura F, Walker BA, Bustoros M, Stewart AK, Usmani SZ, Hillengass J, Chng WJ, Keats JJ, Martinez-Lopez J, Sperling AS, Touzeau C, Zhan F, Raje NS, Cavo M, Bolli N, Ghobrial IM, Dhodapkar MV, Jagannath S, Spencer A, Parekh S, Bahlis NJ, Lonial S, Sonneveld P, Bergsagel L, Orlowski RZ, Morgan G, Mateos MV, Rajkumar SV, San Miguel JF, Anderson KC, Moreau P, Kumar S, Prósper F, Munshi NC (2025). International Myeloma Society/International Myeloma Working Group consensus recommendations on the definition of high-risk multiple myeloma. Journal of Clinical Oncology.
|
|
|
Video of the Week
|
|
| Precision interception in multiple myeloma and it’s precursor conditions |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2018, FDA approved larotrectinib, the first drug that targets tumors with NTRK gene fusions.
|
|
|
|
| -
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
